Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Donato

Showing results (131-140 of 159) with videos related to

Pageof 16
Sort By:
Blood Advances|July 24, 2019
Randomized controlled study of ECP with methoxsalen as first-line treatment of patients with moderate to severe cGVHDMadan Jagasia, Christof Scheid, Gérard Socié, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 27, 2004
The use of high-dose cyclophosphamide, carmustine, and thiotepa plus autologous hematopoietic stem cell transplantation as consolidation therapy for high-risk primary breast cancer after primary surgery or neoadjuvant chemotherapyYee Chung Cheng, Gabriela Rondón, Ying Yang, et al.
Leukemia & Lymphoma|August 23, 2006
High-dose rituximab does not negatively affect peripheral blood stem cell mobilization kinetics in patients with intermediate-grade non-Hodgkin's lymphomaChitra Hosing, Rima M Saliba, Martin Körbling, et al.
Cancers|May 27, 2026
Fluoroquinolone Prophylaxis Uncovers High Prevalence Rates of Fluoroquinolone-Resistant <i>Enterobacterales</i> Colonization in Multiple Myeloma Autologous Transplant Patients: A Prospective Cohort StudyChintan Patel, Austin J Terlecky, Melissa Baker, et al.
Bone Marrow Transplantation|July 27, 2004
Donor leukocyte infusions in relapsed Hodgkin's lymphoma following allogeneic stem cell transplantation: CD3+ cell dose, GVHD and disease responseP Anderlini, S A Acholonu, G-J Okoroji, et al.
Genomics|October 14, 2000
SMARCAD1, a novel human helicase family-defining member associated with genetic instability: cloning, expression, and mapping to 4q22-q23, a band rich in breakpoints and deletion mutants involved in several human diseasesC N Adra, J L Donato, R Badovinac, et al.
European Archives of Paediatric Dentistry : Official Journal of the European Academy of Paediatric Dentistry|May 12, 2026
Anxiety, symptoms of temporomandibular disorders (TMD), and awake bruxism in children: an observational studyL A M Torres, M V Heimer, F J C de Lima, et al.
Cancers|April 14, 2025
Prospective, Randomized, Comparative Study of Myeloablative Fludarabine/Busulfan and Fludarabine/Busulfan/Total Body Irradiation Conditioning in Myeloid DiseasesHyung C Suh, Scott D Rowley, Sukhdeep Kaur, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|October 25, 2008
Low influenza vaccination coverage in asthmatic children in France in 2006-7F Rance, C Chave, J De Blic, et al.
Journal of Biological Regulators and Homeostatic Agents|November 28, 2008
Influence of body mass index, comorbidities and prior systemic therapies on the response of psoriasis to adalimumab: an exploratory analysis from the APHRODITE dataN Cassano, A Galluccio, C De Simone, et al.
Pageof 16

Showing results (131-140 of 159) with videos related to

Sort By:
Pageof 16
Blood Advances|July 24, 2019
Randomized controlled study of ECP with methoxsalen as first-line treatment of patients with moderate to severe cGVHDMadan Jagasia, Christof Scheid, Gérard Socié, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 27, 2004
The use of high-dose cyclophosphamide, carmustine, and thiotepa plus autologous hematopoietic stem cell transplantation as consolidation therapy for high-risk primary breast cancer after primary surgery or neoadjuvant chemotherapyYee Chung Cheng, Gabriela Rondón, Ying Yang, et al.
Leukemia & Lymphoma|August 23, 2006
High-dose rituximab does not negatively affect peripheral blood stem cell mobilization kinetics in patients with intermediate-grade non-Hodgkin's lymphomaChitra Hosing, Rima M Saliba, Martin Körbling, et al.
Cancers|May 27, 2026
Fluoroquinolone Prophylaxis Uncovers High Prevalence Rates of Fluoroquinolone-Resistant <i>Enterobacterales</i> Colonization in Multiple Myeloma Autologous Transplant Patients: A Prospective Cohort StudyChintan Patel, Austin J Terlecky, Melissa Baker, et al.
Bone Marrow Transplantation|July 27, 2004
Donor leukocyte infusions in relapsed Hodgkin's lymphoma following allogeneic stem cell transplantation: CD3+ cell dose, GVHD and disease responseP Anderlini, S A Acholonu, G-J Okoroji, et al.
Genomics|October 14, 2000
SMARCAD1, a novel human helicase family-defining member associated with genetic instability: cloning, expression, and mapping to 4q22-q23, a band rich in breakpoints and deletion mutants involved in several human diseasesC N Adra, J L Donato, R Badovinac, et al.
European Archives of Paediatric Dentistry : Official Journal of the European Academy of Paediatric Dentistry|May 12, 2026
Anxiety, symptoms of temporomandibular disorders (TMD), and awake bruxism in children: an observational studyL A M Torres, M V Heimer, F J C de Lima, et al.
Cancers|April 14, 2025
Prospective, Randomized, Comparative Study of Myeloablative Fludarabine/Busulfan and Fludarabine/Busulfan/Total Body Irradiation Conditioning in Myeloid DiseasesHyung C Suh, Scott D Rowley, Sukhdeep Kaur, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|October 25, 2008
Low influenza vaccination coverage in asthmatic children in France in 2006-7F Rance, C Chave, J De Blic, et al.
Journal of Biological Regulators and Homeostatic Agents|November 28, 2008
Influence of body mass index, comorbidities and prior systemic therapies on the response of psoriasis to adalimumab: an exploratory analysis from the APHRODITE dataN Cassano, A Galluccio, C De Simone, et al.
Pageof 16